SEC EDGAR · company profile · free

ELI LILLY & Co due diligence

Who ELI LILLY & Co (LLY) is on the public record: identity, annual results, what it filed in the last year and why, straight from SEC EDGAR.

1000 filings in EDGAR's recent index, 690 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index and XBRL financial data

At a glance

ELI LILLY & Co (LLY) is a large accelerated filer incorporated in Indiana, classified under SIC 2834 (Pharmaceutical Preparations), and lists on NYSE. Its fiscal year ends December 31. It has also filed as LILLY ELI & CO and LILLY ELI & CO ET AL.

For the fiscal year ended December 31, 2025, its 10-K reported revenue of $65.2B, up 44.7% from the year before, net income of $20.6B, and total assets of $112B.

In the twelve months to October 9, 2026 it made 185 filings on EDGAR, including 1 annual report, 3 quarterly reports, 7 current reports on Form 8-K, and 121 Form 4 insider filings, plus 3 prospectus supplements and free writing prospectuses for its securities offerings. Its 8-Ks were filed most often for results of operations (4), officer or director changes (1), and shareholder vote results (1).

CIK
0000059478
Filer status
Large accelerated filer
Industry (SIC)
Pharmaceutical Preparations (2834)
Incorporated
Indiana
Listed on
NYSE
Tickers
LLY
Fiscal year end
12-31

Annual results

Fiscal year endedRevenueNet incomeTotal assets
2025-12-31$65.2B +44.7%$20.6B +94.9%$112B
2024-12-31$45.0B +32.0%$10.6B +102.1%$78.7B
2023-12-31$34.1B$5.2B$64.0B
As reported in each 10-K's XBRL data on SEC EDGAR (revenue tag Revenues); a later 10-K's restatement replaces the earlier figure.
FilingFiledPeriodAccession
Annual report (10-K)2026-02-122025-12-310000059478-26-000013
Quarterly report (10-Q)2026-08-052026-06-300000059478-26-000081
Current report (8-K)2026-08-052026-08-050000059478-26-000077

Filing activity

185 filings since 2025-10-09, 3 of them prospectus supplements and free writing prospectuses (not listed below). By form:

4
121
144
20
8-K
7
SCHEDULE 13G/A
7
3
6
10-Q
3
SCHEDULE 13D
2
SCHEDULE 13G
2

8-K items in the last 12 months: results of operations (Item 2.02, 4) · officer or director changes (Item 5.02, 1) · shareholder vote results (Item 5.07, 1) · other events (Item 8.01, 1).

FiledFormDocumentPeriod
2026-10-083FORM 32026-10-08
2026-10-07144Form 144 notice of proposed sale
2026-09-224FORM 42026-09-21
2026-09-224FORM 42026-09-21
2026-09-224FORM 42026-09-21
2026-09-224FORM 42026-09-21
2026-09-114FORM 42025-09-22
2026-09-043/AFORM 3/A2025-11-07
2026-09-044FORM 42026-09-02
2026-09-044FORM 42026-09-02
free alert

Free. One email a day at most, only when something changes. Confirm by email first; unsubscribe with one click. Privacy.

The full due-diligence dossier on ELI LILLY & Co

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"LLY"} over x402 or MPP, $0.85

Sample output and API docs · all reports

LLY insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.